Softwave Tissue Regeneration Technologies, LLC
At a glance
EmployeesNot reported
In business sinceNot reported
HeadquartersAlpharetta, GA
US patents13
SAM.gov UEICYLTKWEWZ4A5
CAGE code99L91
Incorporated inGA
LEI549300UQLK4C63T8RK65
What they make
Extracorporeal Shock Wave Device For Treatment Of Diabetic Foot UlcersLithotriptor, Extracorporeal Shock-Wave, UrologicalMassager, Therapeutic, Electric
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
13 US patents granted 2022–2025, 13 of them in the five years to SEP 2025.
Medical technology 13
- Acoustic shock wave or pressure pulse treatment for proptosis or exophthalmosUS 12,402,898 · granted SEP 2, 2025
- Acoustic shock wave treatment and devices for appendagesUS 12,303,721 · granted MAY 20, 2025
- Acoustic shock wave therapeutic methods to prevent or treat opioid addictionUS 11,903,894 · granted FEB 20, 2024
- Handheld acoustic shock wave or pressure pulse application device and methods of useUS 11,844,739 · granted DEC 19, 2023
- Acoustic shock wave therapeutic methodsUS 11,826,301 · granted NOV 28, 2023
Newest 5 shown · Granted to Softwave Tissue Regeneration Technologies, LLC · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Softwave Tissue Regeneration Technologies, LLC | Alpharetta | GA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.